GB

Gautam Bhupendra Parikh

Director Director DIN 00058266
DIN 00058266 First appointment Sep 1985 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 1985
Shareholding value •••• Premium profile

About Gautam Bhupendra Parikh

Data last updated:

Gautam Bhupendra Parikh was a Director at Sonteg Pharmaceuticals Private Limited (2009–2021) and Director at Trends Pharma Pvt Ltd (1985–2010). The companies operate in Pharma.

DIN 00058266
Primary Designation Director
Industry Pharma
First Appointment 11 Sep 1985

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Mar 20091995Active
Trends Pharma Pvt Ltd U24230MH1985PTC037469
Director11 Sep 19851985₹11.35 Cr (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Sonteg Pharmaceuticals Private Limited
Trends Pharma Pvt Ltd
Premium access

Shareholding and investment profile for Gautam Bhupendra Parikh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gautam Bhupendra Parikh

Gautam Bhupendra Parikh was first appointed on 11 Sep 1985 as Director at Trends Pharma Pvt Ltd. The most recent appointment on record is 31 Mar 2009 at Sonteg Pharmaceuticals Private Limited.

Gautam Bhupendra Parikh held 2 earlier board appointments: Sonteg Pharmaceuticals Private Limited (Director, 31 Mar 2009 to 31 Mar 2021); Trends Pharma Pvt Ltd (Director, 11 Sep 1985 to 31 Mar 2010).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available